DUC NGUYEN: Open Payments
NPI 1376060319 · RESEDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 10 payments from 2 companies in 2025. Trend: 2023 $247 · 2024 $80 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $232 |
| Janssen Pharmaceuticals, Inc | 1 | $36 |
Products named: AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
